Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients

Published:2023-11 Issue: Volume:168 Page:105584
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Schiaroli Elisabetta^ORCID,Gidari Anna,Brachelente Giovanni,Bicchieraro Giulia,Spaccapelo Roberta^ORCID,Bastianelli Sabrina,Pierucci Sara,Busti Chiara,Pallotto Carlo,Malincarne Lisa,Camilloni Barbara^ORCID,Falcinelli Flavio,De Socio Giuseppe Vittorio,Villa Alfredo,Mencacci Antonella,Francisci Daniela

Funder

Fondazione Cassa di Risparmio di Perugia

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference28 articles.

1. COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety;Fendler;Nat. Rev. Clin. Oncol.,2022

2. Factors associated with COVID-19-related death using open SAFELY;Williamson;Nature,2020

3. Outcomes of patients with hematologic malignancies and COVID-19. Meta-analysis;Vijenthira;Blood,2020

4. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer;Aydillo;N. Engl. J. Med.,2020

5. Persistence and evolution of SARS-CoV-2 in an immunocompromised host;Choi;N. Engl. J. Med.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP